Characterization of orally active nonpeptide vasopressin V(2) receptor agonist. Synthesis and biological evaluation of both the (5R)- and (5S)-enantioisomers of 2-[1-(2-Chloro-4-pyrrolidin-1-yl-benzoyl)-2,3,4,5-tetrahydro-1H-1-benzazepin- 5-yl]-N-isopropylacetamide

J Med Chem. 2002 Aug 15;45(17):3805-8. doi: 10.1021/jm020133q.

Abstract

The synthesis and evaluation of both the (R)- and (S)-enantioisomers about the 5-position on a tetrahydro-1H-1-benzazepine derivative were described. The absolute configuration of the (R,R)-isomer (10) was determined by X-ray crystallographic analysis. After evaluation of both enantiomers (compounds R-2, S-2) for binding affinity, cAMP accumulation, and an in vivo study using Brattleboro rats, R-2 showed more potent activity as a V(2) receptor agonist than S-2.

Publication types

  • Comparative Study

MeSH terms

  • Administration, Oral
  • Animals
  • Crystallography, X-Ray
  • Cyclic AMP / biosynthesis
  • HeLa Cells
  • Humans
  • Radioligand Assay
  • Rats
  • Rats, Brattleboro
  • Receptors, Vasopressin / agonists*
  • Stereoisomerism
  • Structure-Activity Relationship

Substances

  • Receptors, Vasopressin
  • Cyclic AMP